Unit Dose Nasal Spray
Product Description
Grünenthal GmbH
-comp245299.svg)
-
DE -
2015On CPHI since
-
4Certificates
-
1000 - 4999Employees
Company types
.jpg)
Categories
Specifications
Grünenthal GmbH
-
DE
-
2015On CPHI since
-
4Certificates
-
1000 - 4999Employees
Company types
More Products from Grünenthal GmbH (13)
-
Product Risperidone drops 1mg
Risperidone drops 1mg/ml x 30 ml -
Product Simeticone 4%
Simeticone 4% 15ml drops -
Product Biopharma Assembly and Packaging
Biopharma Assembly and Packaging Services
When contracting medicine supply for patients, it is essential to have a partner that delivers excellence. Read more about Grünenthal PRO: https://www.grunenthal-pro.com -
Product Sterile Ampoule Filling/Packaging
Sterile Ampoule Filling/Packaging -
Product Integrated Manufacturing Services
Integrated Manufacturing Services -
.png)
Product Wallet Packaging
We are also highly experienced in the handing of controlled substances.
-
Product Tramadol HCl
Grünenthal GmbH offers a selected range of products which includes Tramadol HCl, as API, bulk and/ or finished dosage form. Please contact us for more information.
-
Product Betahistine 12.5 mg/ml Oral Drops
Glass bottle containing 100 ml oral solution with disposal pump. -
Product Betahistine diHCl
Grünenthal GmbH offers a selected range of products which includes Betahistine diHCl, as API, bulk tablets and/ or finished dosage form. Please contact us for more information.
-
Product Pregabalin FDF
Pregabalin 75 and 150 mg tablets -
Product Calcium carbonate + vit D3
Calcium carbonate + vit D3 tablets -
Product Calcium carbonate 320 mg & 450mg
Calcium carbonate 320 mg& 450mg tablets
Grünenthal GmbH resources (4)
-
News Grünenthal Responsibility Report 2023
Grünenthal’s strategy and culture are closely tied to its deep commitment to conducting business responsibly. We aim to have a net-positive impact on patients, employees, partners, and wider society. Each year, we publish our progress in a detailed and externally audited report – in line with the Global Reporting Initiative (GRI) standards.
-
News Grünenthal Report 2023-2024
4,400 Grünenthal employees worldwide join forces every day to drive progress towards our vision of a World Free of Pain. Together, we achieved record revenues in 2023. And our scientists made important progress with developing innovative medicines for pain patients.
Our most recent report shares information about our company’s strategy, highlight projects and financial performance
-
News Strong new ESG rating puts Grünenthal in top 2% of the pharmaceuticals subindustry
The latest independent rating confirms Grünenthal’s improved approach to managing Environmental, Social and Governance (ESG) topics – and evaluates the company as the leader in its peer group, with a low ESG risk rating. -
News EcoVadis Gold Medal!
We are celebrating an EcoVadis gold medal!
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance